Victoza, a type 2 diabetes drug, may cause pancreatic cancer. Manufacturer Novo Nordisk faces lawsuits for allegedly failing to warn patients and doctors about this risk.
Pradaxa
The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015, leading to hundreds of casualties.
Kombiglyze XR
Patients taking type 2 diabetes drug Kombiglyze XR may have a greater risk of heart failure. AstraZeneca is now battling lawsuits alleging they failed to warn of this risk.
Taxotere
Temporary hair loss is common during chemotherapy, but permanent hair loss may be more common with Taxotere than with other types of chemo drugs.
Invega
The antipsychotic drug Invega can cause young boys to develop female breast tissue (gynecomastia). Many have filed lawsuits against drug maker Johnson & Johnson.
Risperdal
The antipsychotic drug Risperdal can cause boys to develop female breast tissue (gynecomastia). Many have filed lawsuits against drug maker Johnson & Johnson.
Actemra
Roche's rheumatoid arthritis drug Actemra has been linked to more than 1,100 deaths. So why doesn't it have warning labels about potentially fatal side effects?
Zofran
Zofran is often prescribed off-label to help pregnant women treat morning sickness. Unfortunately, it has been linked to congenital birth defects.
Benicar
The blood pressure medication Benicar has been linked to severe gastrointestinal injuries, including a condition known as sprue-like enteropathy.
Lipitor
Research suggests that the cholesterol medication Lipitor by drug maker Pfizer can increase the risk of type 2 diabetes.
Eliquis
The blood thinner Eliquis (apixaban) has been linked to serious, potentially fatal bleeding that that cannot be reversed with an antidote.
Propecia
The hair loss drug Propecia can cause lasting sexual side effects in men, even after they have discontinued its use. As a result, many have filed lawsuits against drugmaker Merck.
